For the most part I didnt have side effects, a little light headed here and there but definitely helped suppress my appetite which I enjoyed
While increased adiposity (i.e., overweight and obesity) is the usual driver of IR, other factors may play a role in the development of IR in T1D
For us as clinicians, the 2035 projections map directly onto the chronic disease burden we'll be managingmore diabetes, more cardiovascular disease, more musculoskeletal disease, more Alzheimer's, and higher costs across the board
GLP-1 receptor agonists work by mimicking the action of endogenous GLP-1, an incretin hormone released from intestinal L-cells in response to food intake
GLP-1 helps regulate blood sugar, slows gastric emptying, and reduces appetite, making these medications effective for both type 2 diabetes management and weight loss
Delayed gastric emptying : By slowing the rate at which food leaves the stomach, GLP-1 agonists help moderate post-prandial glucose excursions and promote satiety